NCT02973789: A trial that was reported late by NovoCure GmbH
This trial has reported, although it was 14 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02973789 |
|---|---|
| Title | LUNAR: Pivotal, Randomized, Open-label Study of Tumor Treating Fields (TTFields) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Dec. 31, 2016 |
| Completion date | Sept. 24, 2024 |
| Required reporting date | Sept. 24, 2025, midnight |
| Actual reporting date | Oct. 8, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 14 |